Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4826
ProShares Short 20+ Year Treasury ETF
TBF
$104M
| $153K | ﹤0.01% |
7,000
| – | – |
|
4827
HCI Group
HCI
$2.28B
| $152K | ﹤0.01% |
5,105
+2,918
| +133% | +$97.2K |
|
4828
iShares Expanded Tech Sector ETF
IGM
$10.6B
| $152K | ﹤0.01% |
5,400
| – | – |
|
4829
PUT
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $152K | ﹤0.01% |
4,000
+3,500
| +700% | +$129K |
|
|
HSKA
4830
DELISTED
Heska Corp
HSKA
| $152K | ﹤0.01% |
1,894
+364
| +24% | +$32.1K |
|
4831
AngioDynamics
ANGO
$622M
| $151K | ﹤0.01% |
9,084
+4,084
| +82% | +$69.7K |
|
4832
Pathward Financial
CASH
$1.89B
| $151K | ﹤0.01% |
4,863
-29,214
| -86% | -$847K |
|
4833
Evogene
EVGN
$7.64M
| $151K | ﹤0.01% |
4,933
| – | – |
|
4834
PUT
ING
ING
$103B
| $151K | ﹤0.01% |
8,200
-4,400
| -35% | -$80.7K |
|
4835
ProShares Ultra Financials
UYG
$861M
| $151K | ﹤0.01% |
3,540
+1,425
| +67% | +$57.4K |
|
|
SJR
4836
DELISTED
Shaw Communications Inc.
SJR
| $151K | ﹤0.01% |
6,598
-36,564
| -85% | -$824K |
|
4837
HealthStream
HSTM
$818M
| $150K | ﹤0.01% |
6,486
-164
| -2% | -$3.86K |
|
4838
Lineage Cell Therapeutics
LCTX
$284M
| $150K | ﹤0.01% |
79,593
+76,447
| +2,430% | +$167K |
|
|
EVBG
4839
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $150K | ﹤0.01% |
5,032
+4,640
| +1,184% | +$126K |
|
|
FMI
4840
PUT
DELISTED
Foundation Medicine, Inc.
FMI
| $150K | ﹤0.01% |
+2,200
| New | +$114K |
|
4841
CALL
Marriott Vacations Worldwide
VAC
$3.49B
| $149K | ﹤0.01% |
1,100
-400
| -27% | -$52.8K |
|
|
AMID
4842
DELISTED
American Midstream Partners, LP
AMID
| $149K | ﹤0.01% |
11,198
+1,035
| +10% | +$13.6K |
|
|
WRD
4843
DELISTED
WildHorse Resource Development
WRD
| $149K | ﹤0.01% |
8,114
+7,615
| +1,526% | +$114K |
|
|
DCH
4844
CALL
Dauch Corp
DCH
$1.42B
| $148K | ﹤0.01% |
8,700
+5,900
| +211% | +$104K |
|
4845
BlackLine
BL
$1.79B
| $148K | ﹤0.01% |
4,494
+4,130
| +1,135% | +$145K |
|
4846
Southside Bancshares
SBSI
$973M
| $148K | ﹤0.01% |
4,396
+3,770
| +602% | +$133K |
|
4847
PUT
Suburban Propane Partners
SPH
$1.18B
| $148K | ﹤0.01% |
6,100
+5,300
| +663% | +$132K |
|
|
MAGN
4848
Magnera Corp
MAGN
$482M
| $148K | ﹤0.01% |
530
+453
| +588% | +$118K |
|
|
BMTC
4849
DELISTED
Bryn Mawr Bank Corp
BMTC
| $148K | ﹤0.01% |
3,364
+2,575
| +326% | +$114K |
|
4850
CALL
ProShares Ultra Energy
DIG
$76.5M
| $147K | ﹤0.01% |
2,960
-2,160
| -42% | -$96.5K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.